vs

Side-by-side financial comparison of AVIENT CORP (AVNT) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

AVIENT CORP is the larger business by last-quarter revenue ($760.6M vs $510.9M, roughly 1.5× Genius Sports Ltd). AVIENT CORP runs the higher net margin — 2.2% vs -12.3%, a 14.6% gap on every dollar of revenue. AVIENT CORP produced more free cash flow last quarter ($125.4M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs -4.2%).

Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

AVNT vs GENI — Head-to-Head

Bigger by revenue
AVNT
AVNT
1.5× larger
AVNT
$760.6M
$510.9M
GENI
Higher net margin
AVNT
AVNT
14.6% more per $
AVNT
2.2%
-12.3%
GENI
More free cash flow
AVNT
AVNT
$55.8M more FCF
AVNT
$125.4M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
-4.2%
AVNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AVNT
AVNT
GENI
GENI
Revenue
$760.6M
$510.9M
Net Profit
$16.9M
$-63.0M
Gross Margin
30.2%
25.2%
Operating Margin
5.2%
-11.5%
Net Margin
2.2%
-12.3%
Revenue YoY
1.9%
Net Profit YoY
-65.0%
EPS (diluted)
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVNT
AVNT
GENI
GENI
Q4 25
$760.6M
$510.9M
Q3 25
$806.5M
$335.4M
Q2 25
$866.5M
$215.2M
Q1 25
$826.6M
$119.7M
Q4 24
$746.5M
$413.0M
Q3 24
$815.2M
$285.8M
Q2 24
$849.7M
$184.1M
Q1 24
$829.0M
$97.2M
Net Profit
AVNT
AVNT
GENI
GENI
Q4 25
$16.9M
$-63.0M
Q3 25
$32.6M
Q2 25
$52.6M
$-47.3M
Q1 25
$-20.2M
$-25.5M
Q4 24
$48.3M
$-85.5M
Q3 24
$38.2M
$-47.1M
Q2 24
$33.6M
$-35.5M
Q1 24
$49.4M
$-25.2M
Gross Margin
AVNT
AVNT
GENI
GENI
Q4 25
30.2%
25.2%
Q3 25
30.4%
24.2%
Q2 25
32.1%
19.1%
Q1 25
31.8%
10.7%
Q4 24
34.8%
16.7%
Q3 24
32.1%
20.5%
Q2 24
30.3%
18.6%
Q1 24
33.6%
9.8%
Operating Margin
AVNT
AVNT
GENI
GENI
Q4 25
5.2%
-11.5%
Q3 25
8.3%
-15.3%
Q2 25
11.1%
-21.0%
Q1 25
0.1%
-20.3%
Q4 24
11.5%
-18.0%
Q3 24
9.5%
-13.9%
Q2 24
8.5%
-16.8%
Q1 24
11.3%
-23.7%
Net Margin
AVNT
AVNT
GENI
GENI
Q4 25
2.2%
-12.3%
Q3 25
4.0%
Q2 25
6.1%
-22.0%
Q1 25
-2.4%
-21.3%
Q4 24
6.5%
-20.7%
Q3 24
4.7%
-16.5%
Q2 24
4.0%
-19.3%
Q1 24
6.0%
-25.9%
EPS (diluted)
AVNT
AVNT
GENI
GENI
Q4 25
$0.18
Q3 25
$0.36
Q2 25
$0.57
Q1 25
$-0.22
Q4 24
$0.53
Q3 24
$0.41
Q2 24
$0.36
Q1 24
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVNT
AVNT
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$280.6M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$2.4B
$724.5M
Total Assets
$6.0B
$1.1B
Debt / EquityLower = less leverage
0.81×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVNT
AVNT
GENI
GENI
Q4 25
$280.6M
Q3 25
$110.2M
Q2 25
$110.2M
Q1 25
$110.2M
Q4 24
$100.3M
Q3 24
$100.3M
Q2 24
$100.3M
Q1 24
$100.3M
Total Debt
AVNT
AVNT
GENI
GENI
Q4 25
$1.9B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$2.1B
Q1 24
$2.1B
Stockholders' Equity
AVNT
AVNT
GENI
GENI
Q4 25
$2.4B
$724.5M
Q3 25
$2.4B
$572.4M
Q2 25
$2.4B
$572.4M
Q1 25
$2.3B
$572.4M
Q4 24
$2.3B
$573.0M
Q3 24
$2.4B
$573.0M
Q2 24
$2.3B
$573.0M
Q1 24
$2.3B
$573.0M
Total Assets
AVNT
AVNT
GENI
GENI
Q4 25
$6.0B
$1.1B
Q3 25
$6.1B
$792.3M
Q2 25
$6.1B
$792.3M
Q1 25
$5.8B
$792.3M
Q4 24
$5.8B
$775.7M
Q3 24
$6.0B
$775.7M
Q2 24
$5.9B
$775.7M
Q1 24
$5.9B
$775.7M
Debt / Equity
AVNT
AVNT
GENI
GENI
Q4 25
0.81×
Q3 25
0.83×
Q2 25
0.86×
Q1 25
0.90×
Q4 24
0.89×
Q3 24
0.88×
Q2 24
0.90×
Q1 24
0.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVNT
AVNT
GENI
GENI
Operating Cash FlowLast quarter
$167.8M
$81.9M
Free Cash FlowOCF − Capex
$125.4M
$69.6M
FCF MarginFCF / Revenue
16.5%
13.6%
Capex IntensityCapex / Revenue
5.6%
2.4%
Cash ConversionOCF / Net Profit
9.93×
TTM Free Cash FlowTrailing 4 quarters
$195.0M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVNT
AVNT
GENI
GENI
Q4 25
$167.8M
$81.9M
Q3 25
$72.1M
$-4.8M
Q2 25
$112.8M
$-1.2M
Q1 25
$-51.1M
$-14.6M
Q4 24
$122.6M
$14.9M
Q3 24
$71.1M
$-9.2M
Q2 24
$105.9M
Q1 24
$-42.8M
Free Cash Flow
AVNT
AVNT
GENI
GENI
Q4 25
$125.4M
$69.6M
Q3 25
$47.4M
$-14.2M
Q2 25
$85.8M
$-5.8M
Q1 25
$-63.6M
$-16.0M
Q4 24
$81.5M
$11.3M
Q3 24
$46.1M
$-11.6M
Q2 24
$74.5M
Q1 24
$-67.2M
FCF Margin
AVNT
AVNT
GENI
GENI
Q4 25
16.5%
13.6%
Q3 25
5.9%
-4.2%
Q2 25
9.9%
-2.7%
Q1 25
-7.7%
-13.4%
Q4 24
10.9%
2.7%
Q3 24
5.7%
-4.1%
Q2 24
8.8%
Q1 24
-8.1%
Capex Intensity
AVNT
AVNT
GENI
GENI
Q4 25
5.6%
2.4%
Q3 25
3.1%
2.8%
Q2 25
3.1%
2.1%
Q1 25
1.5%
1.2%
Q4 24
5.5%
0.9%
Q3 24
3.1%
0.9%
Q2 24
3.7%
Q1 24
2.9%
Cash Conversion
AVNT
AVNT
GENI
GENI
Q4 25
9.93×
Q3 25
2.21×
Q2 25
2.14×
Q1 25
Q4 24
2.54×
Q3 24
1.86×
Q2 24
3.15×
Q1 24
-0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVNT
AVNT

Color Additives And Inks$466.0M61%
Specialty Engineered Materials$295.5M39%

GENI
GENI

Segment breakdown not available.

Related Comparisons